LINC02197

Across TCGA pan-cancer cohorts, LINC02197 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC02197 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02197 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02197 expression acts as an unfavorable survival marker.

COAD and CHOL are the cancer types where LINC02197 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	II,III,IV	0.168	0.788	.005	12	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

LINC02197–COAD (OS)

Open the COAD breakdown →